Spencer Hoover, vice president and executive director of the Henry Ford Cancer Institute, is co-author of a manuscript published in the Journal of Oncology Practice aimed at establishing best practices to promote diversity in clinical trials. In-depth interviews were conducted with leaders from U.S. cancer centers with above average recruitment of racial and ethnic minority […]Continue Reading ...
Autism was first described by U.S. researchers more than 70 years ago, and today the Centers for Disease Control and Prevention (CDC) estimates that 1 in 59 children are identified with autism spectrum disorder (ASD), affecting more than 3.5 million Americans. Although clinical techniques are used to help patients with ASD respond to stress and […]Continue Reading ...
The first evaluation of pharmacists based in accident and emergency departments has concluded that with additional clinical skills, they are able to take on overall clinical responsibility for patients. Daniel Greenwood a PhD student from The University of Manchester studied the work of people they termed Emergency Department Pharmacist Practitioners (EDPPs) from 15 NHS Trusts […]Continue Reading ...
A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials. The researchers were one of ten teams to develop a digital tool to address complex challenges relevant to medical conditions such as cancer […]Continue Reading ...
Critical Path Institute’s (C-Path) Data Collaboration Center (DCC) and the Friedreich’s Ataxia Research Alliance (FARA) today announced the launch of the Friedreich’s Ataxia Integrated Clinical Database (FAICD). The new platform will enable collaborative research and data sharing to support the understanding of natural history, potential biomarkers and clinical endpoints, and promote research into novel clinical […]Continue Reading ...
Prototype web portal shows technology’s potential to protect and streamline the clinical trials process UC San Francisco researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain. The system creates an immutable audit trail that makes it easy to spot any tampering with results — such as making the […]Continue Reading ...
The National Institute for Health and Care Excellence (NICE) has recognized Advanced for demonstrating high standards in producing healthcare guidance. Advanced’s flagship clinical decision support technology, Odyssey, has been renewed on the NICE Accreditation Programme for a further five years to January 2023. Odyssey is designed to support primary care and urgent care assessment of […]Continue Reading ...
The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet. Eighteen healthy adults received the monoclonal antibody as part of a Phase 1 clinical trial that began in May 2018 at the National Institutes of Health (NIH) Clinical Center in Bethesda, […]Continue Reading ...
Right now, Gene Gilmer is as sharp as ever at 90 years of age. A retired school superintendent who earned his doctorate in math decades ago, Gilmer lives alone and worries about losing the memories that defined his life. That’s part of the reason he enrolled in an unusual clinical trial through OHSU in Portland, […]Continue Reading ...
An international panel of the foremost researchers on infectious disease and antimicrobials has formed new guidelines on the use of polymyxins, a class of antibiotics employed as a last resort to treat deadly, drug-resistant bacteria. The guidelines, published last month in Pharmacotherapy, set new standards for the clinical use of polymyxins, including on maximum dosage, […]Continue Reading ...
FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, based at RCSI (Royal College of Surgeons Ireland), has partnered with global biopharmaceutical company, UCB, to unlock the power of healthcare data to inform improvements in clinical care of people with epilepsy. Based on aggregated clinical data analytics, the project will provide insights into […]Continue Reading ...
WEDNESDAY, Feb. 20, 2019 — Structural and clinical barriers prevent most cancer patients from participating in clinical trials, according to a review published online Feb. 19 in the Journal of the National Cancer Institute. Joseph M. Unger, Ph.D., from the Fred Hutchinson Cancer Research Center in Seattle, and colleagues conducted a systematic review and meta-analysis […]Continue Reading ...
After reading another student’s Scope post, I began to notice how often medical students refer to one another as “machines.” We do so in a judgmental tone that ends with the smallest squeak of jealousy. “He’s a total machine” is both an insult and a statement of admiration. It’s also a question: How does he […]Continue Reading ...
The National Institutes of Health has awarded a R01 grant to a multi-institutional team to develop and evaluate a pregnancy-specific Artificial Pancreas in a sequence of in-clinic and transitional environment clinical trials. The researchers hope that the first-in-the-nation studies will lead to a safe and effective at-home clinical trial with an extension phase to the […]Continue Reading ...
Credit: Mary Ann Liebert, Inc., publishers A new Centers for Disease Control and Prevention (CDC) study found that smoking in the three months prior to assisted reproductive technology (ART) treatment was associated with higher adjusted odds of cycle cancellation resulting in no embryo transfer and cancellations before fresh oocyte retrieval or frozen embryo transfer. Associations […]Continue Reading ...
- Inherited form of rickets improves more with new injectable medicine than conventional therapy
- Trastuzumab Tied to Higher Long-Term Risk for Heart Failure
- Personal context directly affects CPAP use
- Mosquito tracking key to preventing disease outbreaks
- Scientists Detect Hidden Signals from Beneficial Bacteria
- Treating women with thyroid antibodies with Levothyroxine do not increase live birth rate
- Brain area that only processes spoken, not written words identified
- Race and ethnicity influence fracture risk in diabetic patients
- Researchers report new regenerative medicine approach for treating osteoarthritis of the knee
- Exposure to dim light at night may contribute to spread of breast cancer to bones
- Benefits of osteoporosis treatment in postmenopausal women outweigh the perceived risks
- Researchers find evidence of Cryptosporidium parasite in Minnesota’s public water systems
- Three Clues to Raised Risk of Miscarriage
- Structured play helps toddlers self-regulate, altering their life course
- Translating horror into justice: Stanford psychiatrist advocates for human rights
- HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range
- Recurrent pregnancy loss may be caused by sperm DNA damage, finds study
- Special Collection tracks development of new diagnostic tests for tuberculosis
- Air Force develops genetic test to predict mental performance
- To abort or not to abort—making difficult choices alone